142 related articles for article (PubMed ID: 23299540)
1. Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma.
Choi Y; Park B; Kim K; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee JE; Lee HM
Br J Cancer; 2013 Feb; 108(2):387-94. PubMed ID: 23299540
[TBL] [Abstract][Full Text] [Related]
2. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
[TBL] [Abstract][Full Text] [Related]
3. Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma.
Magera JS; Leibovich BC; Lohse CM; Sengupta S; Cheville JC; Kwon ED; Blute ML
Urology; 2008 Feb; 71(2):278-82. PubMed ID: 18308103
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma.
Lee SE; Byun SS; Han JH; Han BK; Hong SK
BJU Int; 2006 Dec; 98(6):1228-32. PubMed ID: 17034508
[TBL] [Abstract][Full Text] [Related]
5. Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma.
Kawai Y; Matsuyama H; Korenaga Y; Misumi T; Eguchi S; Hara T; Nagao K; Ohmi C; Sakano S; Naito K
Urol Int; 2009; 83(3):306-10. PubMed ID: 19829031
[TBL] [Abstract][Full Text] [Related]
6. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
Kaffenberger SD; Morgan TM; Stratton KL; Boachie AM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
BJU Int; 2012 Dec; 110(11 Pt B):E641-6. PubMed ID: 22958439
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte sedimentation rate as a prognostic factor in renal cell carcinoma.
Hannisdal E; Bostad L; Grøttum KA; Langmark F
Eur J Surg Oncol; 1989 Aug; 15(4):333-6. PubMed ID: 2759251
[TBL] [Abstract][Full Text] [Related]
9. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
Karakiewicz PI; Trinh QD; Lam JS; Tostain J; Pantuck AJ; Belldegrun AS; Patard JJ
Eur Urol; 2007 Nov; 52(5):1428-36. PubMed ID: 17420085
[TBL] [Abstract][Full Text] [Related]
10. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
11. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
12. Pretherapeutic Plasma Fibrinogen Level is an Independent Survival Predictor in Renal Cell Carcinoma.
Sasaki T; Onishi T
Oncol Res Treat; 2015; 38(7-8):374-8. PubMed ID: 26278582
[TBL] [Abstract][Full Text] [Related]
13. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Blood Type A in Patients with Renal Cell Carcinoma.
Ko K; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Urol J; 2016 Aug; 13(4):2765-72. PubMed ID: 27576883
[TBL] [Abstract][Full Text] [Related]
15. Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry.
Goebell PJ; Müller L; Hübner A; Harich HD; Boller E; Koska M; Jänicke M; Marschner N;
Urol Oncol; 2018 Oct; 36(10):470.e1-470.e9. PubMed ID: 30131294
[TBL] [Abstract][Full Text] [Related]
16. Preoperative anaemia and thrombocytosis predict adverse prognosis in non-metastatic renal cell carcinoma with tumour thrombus.
Xiao R; Xu C; He W; Liu L; Zhang H; Liu C; Ma L
BMC Urol; 2021 Feb; 21(1):31. PubMed ID: 33639914
[TBL] [Abstract][Full Text] [Related]
17. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
Morgan TM; Tang D; Stratton KL; Barocas DA; Anderson CB; Gregg JR; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
Eur Urol; 2011 Jun; 59(6):923-8. PubMed ID: 21295907
[TBL] [Abstract][Full Text] [Related]
18. The Significance of Pregnancy-associated Plasma Protein a Serum Concentration in Clear Cell Renal Cell Carcinoma.
Cechova M; Chocholaty M; Zima T; Babjuk M; Kalousova M
Anticancer Res; 2019 Jun; 39(6):3249-3253. PubMed ID: 31177175
[TBL] [Abstract][Full Text] [Related]
19. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
20. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
